Target intelligence / Profile preview

Trafficking protein particle complex subunit 4 (TRAPPC4)

Target
TRAPPC4
Molecular classification
Other (Core component of the TRAPP complex, which is a multisubunit vesicle trafficking complex), Guanyl-nucleotide exchange factor (GEF), Scaffold/adaptor protein (in recycling endosomes)
01

Overview

Trafficking protein particle complex subunit 4 (TRAPPC4) is a core component of the TRAPP (Transport Protein Particle) complex involved in vesicular trafficking, specifically mediating transport from the endoplasmic reticulum to the Golgi apparatus. It functions as a guanine nucleotide exchange factor (GEF) for Rab/Ypt GTPases, facilitating multiple stages of intracellular vesicle transport and autophagy. In cancer, TRAPPC4 interacts with ERK2 to regulate signaling relevant for cell proliferation and apoptosis and acts as a scaffold in recycling endosomes to maintain cell surface PD-L1 levels, influencing immune checkpoint therapeutic efficacy. Genetic defects in TRAPPC4 disrupt TRAPP complex stability, causing severe neurodevelopmental disorders such as epilepsy, microcephaly, and syndromic intellectual disability[1][2][3][4][5].

Other names
SynbindinTRS23 homologHematopoietic stem/progenitor cell protein 172SBDNCGI-104HSPC172PTD009TRS23SYNBINDINNEDESBA
02

Mechanism of action

Modulation of TRAPPC4 activity could impact PD-L1 cell surface expression, thus altering immune checkpoint blockade efficacy[2]. By affecting ERK1/2 signaling, could theoretically change tumor susceptibility to ERK/MAPK pathway inhibitors[2]. Targeting TRAPPC4 in neurodevelopmental disease could (hypothetically) restore vesicular trafficking in affected patients, but no such specific drugs are described in current literature.

03

Biological functions

Endoplasmic reticulum to Golgi vesicle-mediated transportAutophagyRegulation of ERK-MAPK signaling (cell proliferation, apoptosis)Dendrite postsynaptic membrane traffickingRecycling of PD-L1 and regulation of antitumor immunityScaffold function for RAB11/PD-L1 recycling
04

Disease associations

Cancer (promotes cell proliferation, modulates apoptosis and immune evasion, junction with PD-L1/ERK/immune checkpoint)Neurodevelopmental and neurodegenerative disease (mutations cause developmental delay, epilepsy, brain atrophy/microcephaly—syndromic intellectual disability)Other (potential roles in immune regulation)
05

Safety considerations

No direct safety concerns for targeting TRAPPC4 are established, but its central cell trafficking role suggests potential for off-target/pleiotropic cellular disruption if targeted[4].Mutations cause severe and syndromic developmental disease, indicating dosage and specificity risks[3][4].
06

Interacting drugs

No direct approved drugs known to target TRAPPC4 itself. It is, however, implicated in cancer biology where modulation could theoretically affect sensitivity to checkpoint inhibitor therapies (e.g., anti-PD-L1/PD-1 drugs)[2].
07

Biomarkers

No established biomarkers for direct TRAPPC4 targeting or monitoring.TRAPPC4 mutations (e.g., splice-site variants) serve as disease biomarkers for neurodevelopmental syndromes[3][4].Possibly TRAPPC4 protein levels/activity in tumors as a biomarker for resistance to immune checkpoint therapy[2].

Beyond the preview

Go deeper on Trafficking protein particle complex subunit 4 (TRAPPC4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trafficking protein particle complex subunit 4 (TRAPPC4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call